Last update 19 Apr 2025

ANT-043

Overview

Basic Info

Drug Type
Antibody Fragment-Drug Conjugates (FDCs)
Synonyms
ANT 043, ANT-043
Target
HER2
Action
antagonists
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Breast CancerOvarian CancerStomach Cancer
Inactive Indication-
Originator Organization
Antikor Biopharma Ltd.Antikor Biopharma Ltd.
Active Organization
Essex Bio-Tech Investment Ltd.Antikor Biopharma Ltd.Antikor Biopharma Ltd.
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

100 Clinical Results associated with ANT-043
Login to view more data
100 Translational Medicine associated with ANT-043
Login to view more data
100 Patents (Medical) associated with ANT-043
Login to view more data
100 Deals associated with ANT-043
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPreclinical
Hong Kong
Essex Bio-Tech Investment Ltd.
01 Jul 2021
Breast CancerPreclinical
United Kingdom
Antikor Biopharma Ltd.Antikor Biopharma Ltd.
01 Jul 2021
Ovarian CancerPreclinical
Hong Kong
Essex Bio-Tech Investment Ltd.
01 Jul 2021
Ovarian CancerPreclinical
United Kingdom
Antikor Biopharma Ltd.Antikor Biopharma Ltd.
01 Jul 2021
Stomach CancerPreclinical
Hong Kong
Essex Bio-Tech Investment Ltd.
01 Jul 2021
Stomach CancerPreclinical
United Kingdom
Antikor Biopharma Ltd.Antikor Biopharma Ltd.
01 Jul 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free